Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9639910rdf:typepubmed:Citationlld:pubmed
pubmed-article:9639910lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:9639910lifeskim:mentionsumls-concept:C0053233lld:lifeskim
pubmed-article:9639910lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:9639910lifeskim:mentionsumls-concept:C0596335lld:lifeskim
pubmed-article:9639910pubmed:issue1lld:pubmed
pubmed-article:9639910pubmed:dateCreated1998-8-3lld:pubmed
pubmed-article:9639910pubmed:abstractTextThe nonsteroidal anti-inflammatory agents ketoprofen, tiaprofenic acid, suprofen and tolmetin, together with the anti-hyperlipoproteinemic drug fenofibrate and the anti-arrhythmic amiodarone can be included in the group of benzophenone-derived photosensitizing drugs. They contain a diaryl ketone chromophore and mediate the development of phototoxic reactions. In some cases, photoallergic responses have been reported. These properties have been substantiated in clinical reports, as well as by means of in vivo and in vitro assays. Tolmetin is phototoxic in vitro, however there are no reports on photosensitization by this drug in humans. In general, photochemical and photobiological studies strongly suggest that photosensitization involves formal hydrogen abstraction (either in a single step or via electron transfer followed by proton transfer) by the benzophenone-like chromophore from the excited triplet state. In the case of amiodarone, the radicals generated by photodehalogenation from the triplet are responsible for the photosensitivity side-effects.lld:pubmed
pubmed-article:9639910pubmed:languageenglld:pubmed
pubmed-article:9639910pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9639910pubmed:citationSubsetIMlld:pubmed
pubmed-article:9639910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9639910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9639910pubmed:statusMEDLINElld:pubmed
pubmed-article:9639910pubmed:monthAprlld:pubmed
pubmed-article:9639910pubmed:issn1011-1344lld:pubmed
pubmed-article:9639910pubmed:authorpubmed-author:MirandaM AMAlld:pubmed
pubmed-article:9639910pubmed:authorpubmed-author:BoscáFFlld:pubmed
pubmed-article:9639910pubmed:issnTypePrintlld:pubmed
pubmed-article:9639910pubmed:volume43lld:pubmed
pubmed-article:9639910pubmed:ownerNLMlld:pubmed
pubmed-article:9639910pubmed:authorsCompleteYlld:pubmed
pubmed-article:9639910pubmed:pagination1-26lld:pubmed
pubmed-article:9639910pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:9639910pubmed:meshHeadingpubmed-meshheading:9639910-...lld:pubmed
pubmed-article:9639910pubmed:meshHeadingpubmed-meshheading:9639910-...lld:pubmed
pubmed-article:9639910pubmed:meshHeadingpubmed-meshheading:9639910-...lld:pubmed
pubmed-article:9639910pubmed:meshHeadingpubmed-meshheading:9639910-...lld:pubmed
pubmed-article:9639910pubmed:meshHeadingpubmed-meshheading:9639910-...lld:pubmed
pubmed-article:9639910pubmed:year1998lld:pubmed
pubmed-article:9639910pubmed:articleTitlePhotosensitizing drugs containing the benzophenone chromophore.lld:pubmed
pubmed-article:9639910pubmed:affiliationDepartamento de Química/Instituto de Tecnología Química UPV-CSIC, Universidad Politécnica de Valencia, Spain.lld:pubmed
pubmed-article:9639910pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9639910pubmed:publicationTypeReviewlld:pubmed
pubmed-article:9639910pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9639910lld:pubmed